Cellectis (CLLS) Reports Q2 Loss of EUR0.23/Share
Tweet
Share
E-mailGet Alerts CLLS Hot Sheet
Join SI Premium – FREE
Cellectis (NASDAQ: CLLS) reported Q2 EPS of (EUR0.23), versus (EUR0.43) reported last year. Revenue for the quarter came in at EUR18.14 million, versus EUR8 million reported last year.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
